DKK1 and neoplasm: Since Dkk1 could be one of potential therapeutic targets (52, 54) further studies are needed to determine, whether there is a difference between expression of Dkk1 in tumour tissue and serum of the patient and how any of those would influence the potential use of therapeutics for EC.